Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cangene Receives WinRho Approval | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cangene Receives WinRho Approval

Portugal clears WinRho 1500 LQ

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Cangene Corp.‘s wholly owned subsidiary, Cangene Europe Limited, has received marketing authorization approval for WinRho 1500 LQ in Portugal from the National Authority of Medicines and Health Products, IP (INFARMED).

The company has received a national license to market the product in Portugal for two indications: to prevent Rh0(D) immunization women that are in Rh0(D) negative, and to treat Rh0(D) negative patients after incompatible Rh0(D) positive blood transfusions or other products containing erythrocytes antigens.

John A. Sedor, Cangene’s president and chief executive officer, said: “Today’s approval is a milestone for Cangene and significant news for expectant mothers and other Rh-negative patients in Portugal. By bringing WinRho to Portugal, we have reestablished a foothold in Europe as we drive the growth of Cangene’s flagship product in markets outside of North America.”

The product will be distributed nationally in Portugal by a third party distributor on behalf of Cangene.

Cangene’s contract manufacturing group will be at table #140 at Contract Pharma’s Contracting & Outsourcing Conference & Tabletop Exhibition on Sept. 19! For more information, visit the conference site!

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics